|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 2938615 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13812165.2 |
| Date of filing the European patent application | 2013-12-04 | |
| (97) | Date of publication of the European application | 2015-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
| (46) | Date of publication of the claims translation | 2016-12-27 |
| (86) | Number | PCT/IB2013/060631 |
| Date | 2013-12-04 |
| (87) | Number | WO 2014/091368 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261737157 P | 2012-12-14 | US |
| (72) |
OMOTO, Kiyoyuki, GB
OWEN, Robert McKenzie, GB
PRYDE, David Cameron, GB
WATSON, Christine Anne Louise, GB
TAKEUCHI, Mifune, GB
|
| (73) |
Pfizer Limited,
Ramsgate Road, Sandwich, Kent CT13 9NJ,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazopiridazino dariniai, kaip GABAA receptorių moduliatoriai |
| IMIDAZOPYRIDAZINE DERIVATIVES AS GABAA RECEPTOR MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2018-11-20 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-12-04 |